RA Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-172,602
| Closed | -$2.07M | – | 82 |
|
|
2022
Q2 | $2.07M | Buy |
+172,602
| New | +$2.07M | 0.06% | 80 |
|
|
2021
Q2 | – | Sell |
-936,583
| Closed | -$92.3M | – | 93 |
|
|
2021
Q1 | $92.3M | Sell |
936,583
-13,655
| -1% | -$1.35M | 1.39% | 21 |
|
|
2020
Q4 | $103M | Buy |
950,238
+9,152
| +1% | +$992K | 1.44% | 22 |
|
|
2020
Q3 | $96.9M | Buy |
941,086
+160,922
| +21% | +$16.6M | 1.77% | 17 |
|
|
2020
Q2 | $163M | Buy |
780,164
+52,893
| +7% | +$11M | 3.17% | 8 |
|
|
2020
Q1 | $71.1M | Buy |
+727,271
| New | +$71.1M | 2.24% | 17 |
|